Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
, , , et
16 févr. 2016
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 16 févr. 2016
Pages: 80 - 86
Reçu: 02 févr. 2015
Accepté: 23 févr. 2015
DOI: https://doi.org/10.1515/raon-2015-0026
Mots clés
© 2016 Radiol Oncol
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Vodusek, Ana Lina
Department of Radiation Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Gazic, Barbara
Department of Pathology, Institute of Oncology LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Jazbec, Janez
Department of Hematology and Oncology, University Children’s HospitalLjubljana, Slovenia